These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26394508)

  • 21. [The Characteristics of Law-evading Drug Users and Effective Approaches].
    Kondo A
    Yakugaku Zasshi; 2016; 136(1):89-94. PubMed ID: 26725673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Spice in France: mixed herbs containing synthetic cannabinoids].
    Schlatter J; Chiadmi F; Chariot P
    Ann Biol Clin (Paris); 2012; 70(4):413-22. PubMed ID: 22796613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spice drugs as a new trend: mode of action, identification and legislation.
    Vardakou I; Pistos C; Spiliopoulou Ch
    Toxicol Lett; 2010 Sep; 197(3):157-62. PubMed ID: 20566335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging drugs of abuse.
    Nelson ME; Bryant SM; Aks SE
    Emerg Med Clin North Am; 2014 Feb; 32(1):1-28. PubMed ID: 24275167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
    Every-Palmer S
    Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA sequence analyses of blended herbal products including synthetic cannabinoids as designer drugs.
    Ogata J; Uchiyama N; Kikura-Hanajiri R; Goda Y
    Forensic Sci Int; 2013 Apr; 227(1-3):33-41. PubMed ID: 23092848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death.
    Tomiyama K; Funada M
    Toxicol Appl Pharmacol; 2014 Jan; 274(1):17-23. PubMed ID: 24211273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic cannabinoid use: recognition and management.
    Castellanos D; Thornton G
    J Psychiatr Pract; 2012 Mar; 18(2):86-93. PubMed ID: 22418399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicological findings of synthetic cannabinoids in recreational users.
    Kronstrand R; Roman M; Andersson M; Eklund A
    J Anal Toxicol; 2013 Oct; 37(8):534-41. PubMed ID: 23970540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".
    Coppola M; Mondola R
    Toxicol Lett; 2012 Jun; 211(2):144-9. PubMed ID: 22459606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of drug codes for 26 substances. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2013 Jan; 78(3):664-6. PubMed ID: 23289157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Kiken drugs: current status of abuse among youth in the nightlife areas of Tokyo].
    Shimane T
    Nihon Rinsho; 2015 Sep; 73(9):1491-6. PubMed ID: 26394509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The current situation of aggravated intoxication with "kiken" drugs (law-evading drugs)].
    Akashi A; Kashiura M; Mikami M; Hamabe Y
    Chudoku Kenkyu; 2016 Mar; 29(1):21-5. PubMed ID: 27255020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological and biochemical interactions between opioids and cannabinoids.
    Manzanares J; Corchero J; Romero J; Fernández-Ruiz JJ; Ramos JA; Fuentes JA
    Trends Pharmacol Sci; 1999 Jul; 20(7):287-94. PubMed ID: 10390647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurochemical basis of cannabis addiction.
    Maldonado R; Berrendero F; Ozaita A; Robledo P
    Neuroscience; 2011 May; 181():1-17. PubMed ID: 21334423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploratory comparative study on the diffusion of synthetic cannabinoids and synthetic cathinones.
    Arfken CL; Owens D; Madeja C; DeAngelis C
    J Psychoactive Drugs; 2014; 46(5):362-8. PubMed ID: 25364986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical characteristics of dappou herb use--disorder patients at the drug dependence clinic: a comparison with methamphetamine use-disorder patients].
    Tanibuchi Y; Matsumoto T; Kobayashi O; Wada K
    Seishin Shinkeigaku Zasshi; 2013; 115(5):463-76. PubMed ID: 23855225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic cannabinoid intoxication: a case series and review.
    Harris CR; Brown A
    J Emerg Med; 2013 Feb; 44(2):360-6. PubMed ID: 22989695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoid tolerance and dependence: a review of studies in laboratory animals.
    González S; Cebeira M; Fernández-Ruiz J
    Pharmacol Biochem Behav; 2005 Jun; 81(2):300-18. PubMed ID: 15919107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
    McCarberg BH; Barkin RL
    Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.